AAA's Lutathera Phase III Meets Primary Endpoint and Data will be Presented in Presidential Session at ECC 2015
16 September 2015
Download
Raptor Pharmaceutical Corp. Expands Rare Disease Portfolio With the Acquisition of Quinsair(TM)
20 August 2015
Download
Allena Pharmaceuticals Initiates Phase 2b Trial of ALLN-177 for Secondary Hyperoxaluria
4 August 2015
Download
Gynesonics raises $43 million in equity financing
22 July 2015
Download
AnaptysBio secures $40 million series D financing
15 July 2015
Download
Celgene to acquire Receptos, advancing leadership in immune-inflammatory diseases
14 July 2015
Download
MEDIAN Technologies announces a private placement of €19.8 Million at a €12 share price
3 July 2015
Download
AAA completes 23 million Euro capital increase with US-based institutions
23 June 2015
Download
Advanced Accelerator Applications reports over 24% growth in sales for the first quarter of 2015
15 June 2015
Download
Eye Diagnostics Innovator i-Optics Closes EUR 13.7 Million Financing Round
22 May 2015
Download
Curetis to Launch Next-Generation Pneumonia Application at ECCMID 2015
16 April 2015
Download
New Clinical Data Show Biological Activity of DLX105 in Patients with Behçet’s Disease
14 April 2015
Download
AAA Reports 29.8% Sales Growth in 2014 and Completes Enrollment in Lutathera Phase III Trial
9 April 2015
Download
Nabriva Therapeutics Announces Financing of up to $120M to Advance Clinical Development of New Class of Antibiotic
7 April 2015
Download
APR Applied Pharma Research s.a. (“APR”) today announced that HBM BioCapital II, a fund advised by HBM Partners Ltd, has acquired a minority stake in APR.
25 March 2015
Download
Allena Pharmaceuticals Announces Positive Phase 2a Data of ALLN-177 for the Treatment of Hyperoxaluria
18 March 2015
Download
Curetis Closes EUR 14.5 Million Extension of Series B Financing
24 November 2014
Download
AAA Reports Over 25% Growth in Sales for the First Nine Months of 2014
20 November 2014
Download
Allena Pharmaceuticals Presents Phase 1 Data on ALLN-177
17 November 2014
Download
Paratek Pharmaceuticals Completes Merger With Transcept Pharmaceuticals
30 October 2014
Download
Probiodrug raises €22 5 million in successful Initial Public Offering and listing on Euronext Amsterdam
23 October 2014
Download
Nabriva Therapeutics Receives FDA Fast Track Status For Lefamulin
8 October 2014
Download
Probiodrug plans IPO on Euronext Amsterdam
25 September 2014
Download
PTC Therapeutics prepares for commercial launch of Translarna
17 September 2014
Download
Ophthotech reports Fovista effects on sub-retinal fibrosis in wet AMD
16 September 2014
Download